Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
From - National Intelligence Report
In a new report to Congress, the Centers for Medicare & Medicaid Services reports the Program Integrity activities have saved Medicare and…
From - National Intelligence Report
June 30, the Department of Justice (DOJ) published an Interim Final Rule in the Federal Register that has significant ramifications for enforcement under the…
From - National Intelligence Report
While the long awaited release of the PAMA rule has received a lot of attention, a significant False Claims Act (FCA) decision by the U.S. Supreme Court was also…
From - National Intelligence Report
While Big Data can mean new opportunities for increasing efficiencies and revenues for the laboratory industry, the Centers for Medicare & Medicaid Services (CMS) claims Big Data has yielded big savings for…